Transurethral microwave thermotherapy with the CoreTherm®Concept in men with prostates larger than 100 grams – a consecutive case series
DOI:
https://doi.org/10.2340/sju.v60.42784Keywords:
Benign prostatic hyperplasia, benign prostatic obstruction, CoreTherm®Concept, large glands, lower urinary tract symptoms, transurethral temperature feedback thermotherapy, transurethral microwave thermotherapyAbstract
Objective: Transurethral microwave thermotherapy (TUMT) is well described for lower urinary tract symptoms in men with prostates between 30 and 100 grams. We aimed to describe the results in men with prostates larger than 100 grams.
Material and methods: We retrospectively recorded age, prostate size, occurrence of urinary retention, and Danish Prostate Symptom Score (DAN-PSS) prior to treatment in men with prostates exceeding 100 grams. Following treatment, we assessed satisfaction, DAN-PSS, and the results of uroflowmetry and postvoid residual urine.
Results: We included 50 consecutive patients with prostates over 100 g. The median age was 78 years, and the median prostate size was 126 g (range 101–230). Forty-four men were treated due to urinary retention and 6 due to lower urinary tract symptoms. Treatments were performed under local anesthesia. The median duration was 15 minutes (range 8–32 minutes) and the median destruction was 25% of the prostatic volume (range 11–26%). Eight patients had destruction of <20%. No side effects were noted.
Forty-nine patients completed 6-month follow-up. The 41/49 (84%) men who had tissue destruction of ≥20% reported to be satisfied. The median DAN-PSS score was 3 (range 0–18), the median Qmax was 12 mL/s (range 5.1–23.1 mL/s) and the median postvoid residual volume was 89 mL (range 0–331 mL). Symptoms were unchanged in the 8/49 (16%) men who had <20% tissue destruction.
Conclusions: TUMT represents a useful alternative to surgery in men with infravesical obstruction and a prostate of more than 100 grams.
Downloads
References
Cornu J-N, Dupuis H, Gazdovich S. Hot topics of the past decade: evolutions and revolutions in lower urinary tract symptoms. Eur Urol Focus. 2022;8:371–374. https://doi.org/10.1016/j.euf.2022.03.012 DOI: https://doi.org/10.1016/j.euf.2022.03.012
Franco JV, Garegnani L, Escobar Liquitay CM, et al. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Cochrane Database Syst Rev. 2021;6:CD004135. https://doi.org/10.1002/14651858.CD004135.pub4 DOI: https://doi.org/10.1002/14651858.CD004135.pub4
Cornu J-N, Zantek P, Burtt G, et al. Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis. Eur Urol. 2023;83:534–547. https://doi.org/10.1016/j.eururo.2023.02.028 DOI: https://doi.org/10.1016/j.eururo.2023.02.028
Stenmark F, Brudin L, Kjölhede H, et al. Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 mL: an evaluation of short- and long-term retreatment risk. Scand J Urol. 2022;56:336–341. https://doi.org/10.1080/21681805.2022.2108139 DOI: https://doi.org/10.1080/21681805.2022.2108139
Hansen BJ, Flyger H, Brasso K, et al. Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol. 1995;76(4):451–458. DOI: https://doi.org/10.1111/j.1464-410X.1995.tb07744.x
Aagaard MF, Niebuhr MH, Jacobsen JD, et al. Transurethral microwave thermotherapy treatment of chronic urinary retention in patients unsuitable for surgery. Scand J Urol. 2014;48:290–294. https://doi.org/10.3109/21681805.2013.840857 DOI: https://doi.org/10.3109/21681805.2013.840857
Larson TR, Blute ML, Bruskewitz RC, et al. A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology. 1998;51:731–742. https://doi.org/10.1016/s0090-4295(97)00710-3 DOI: https://doi.org/10.1016/S0090-4295(97)00710-3
Brehmer M, Wiksell H, Kinn A. Sham treatment compared with 30 or 60 min of thermotherapy for benign prostatic hyperplasia: a randomized study. BJU Int. 1999;84:292–296. https://doi.org/10.1046/j.1464-410x.1999.00234.x DOI: https://doi.org/10.1046/j.1464-410x.1999.00234.x
Francisca EA, d’Ancona FC, Hendriks JC, et al. Quality of life assessment in patients treated with lower energy thermotherapy (Prostasoft 2.0): results of a randomized transurethral microwave thermotherapy versus sham study. J Urol. 1997;158:1839–1844. https://doi.org/10.1016/s0022-5347(01)64141-7 DOI: https://doi.org/10.1016/S0022-5347(01)64141-7
Blute ML, Patterson DE, Segura JW, et al. Transurethral microwave thermotherapy v sham treatment: double-blind randomized study. J Endourol. 1996;10:565–573. https://doi.org/10.1089/end.1996.10.565 DOI: https://doi.org/10.1089/end.1996.10.565
Nawrocki JD, Bell TJ, Lawrence WT, et al. A randomized controlled trial of transurethral microwave thermotherapy. Br J Urol. 1997;79:389–393. https://doi.org/10.1046/j.1464-410x.1997.21515.x DOI: https://doi.org/10.1046/j.1464-410X.1997.21515.x
Roehrborn CG, Preminger G, Newhall P, et al. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial. Urology. 1998;51:19–28. https://doi.org/10.1016/s0090-4295(97)00571-2 DOI: https://doi.org/10.1016/S0090-4295(97)00571-2
Albala DM, Fulmer BR, Turk TMT, et al. Office-based transurethral microwave thermotherapy using the TherMatrx TMx-2000. J Endourol. 2002;16:57–61. https://doi.org/10.1089/089277902753483745 DOI: https://doi.org/10.1089/089277902753483745
Ogden CW, Reddy P, Johnson H, et al. Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet. 1993;341:14–17. https://doi.org/10.1016/0140-6736(93)92482-9 DOI: https://doi.org/10.1016/0140-6736(93)92482-9
Bdesha AS, Bunce CJ, Snell ME, et al. A sham controlled trial of transurethral microwave therapy with subsequent treatment of the control group. J Urol. 1994;152:453–458. https://doi.org/10.1016/s0022-5347(17)32761-1 DOI: https://doi.org/10.1016/S0022-5347(17)32761-1
Sønksen J, Barber NJ, Speakman MJ, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68:643–652. https://doi.org/10.1016/j.eururo.2015.04.024 DOI: https://doi.org/10.1016/j.eururo.2015.04.024
McVary KT, Gange SN, Gittelman MC, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195:1529–1538. https://doi.org/10.1016/j.juro.2015.10.181 DOI: https://doi.org/10.1016/j.juro.2015.10.181
Porpiglia F, Fiori C, Amparore D, et al. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up. BJU Int. 2019;123:1061–1069. https://doi.org/10.1111/bju.14608 DOI: https://doi.org/10.1111/bju.14608
Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;361:k2338. https://doi.org/10.1136/bmj.k2338 DOI: https://doi.org/10.1136/bmj.k2338
Bolmsjö M, Wagrell L, Hallin A, et al. The heat is on – but how? A comparison of TUMT devices. Br J Urol. 1996;78:564–572. https://doi.org/10.1046/j.1464-410x.1996.17213.x DOI: https://doi.org/10.1046/j.1464-410X.1996.17213.x
Walmsley K, Kaplan SA. Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype. J Urol. 2004;172:1249–1255. https://doi.org/10.1097/01.ju.0000129967.30558.ca DOI: https://doi.org/10.1097/01.ju.0000129967.30558.ca
Mattiasson A, Wagrell L, Schelin S, et al. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology. 2007;69:91–97. https://doi.org/10.1016/j.urology.2006.08.1115 DOI: https://doi.org/10.1016/j.urology.2006.08.1115
Francisca EA, d’Ancona FC, Hendriks JC, et al. A randomized study comparing high-energy TUMT to TURP: quality-of-life results. Eur Urol. 2000;38:569–575. https://doi.org/10.1159/000020357 DOI: https://doi.org/10.1159/000020357
Dahlstrand C, Geirsson G, Fall M, et al. Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomized study. Eur Urol. 1993;23:292–298. https://doi.org/10.1159/000474615 DOI: https://doi.org/10.1159/000474615
D’Ancona FC, Francisca EA, Witjes WP, et al. Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol. 1998;81:259–264. https://doi.org/10.1046/j.1464-410x.1998.00542.x DOI: https://doi.org/10.1046/j.1464-410X.1998.00542.x
Ahmed M, Bell T, Lawrence WT, et al. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol. 1997;79:181–185. https://doi.org/10.1046/j.1464-410x.1997.02667.x DOI: https://doi.org/10.1046/j.1464-410X.1997.02667.x
Kaye JD, Smith AD, Badlani GH, et al. High-energy transurethral thermotherapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis. J Endourol. 2008;22:713–718. https://doi.org/10.1089/end.2007.0039 DOI: https://doi.org/10.1089/end.2007.0039
Schelin S, Geertsen U, Walter S, et al. Feedback microwave thermotherapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, randomized, controlled, multicenter study. Urology. 2006;68:795–799. https://doi.org/10.1016/J.UROLOGY.2006.05.020 DOI: https://doi.org/10.1016/j.urology.2006.05.020
Elterman D, Bhojani N, Vannabouathong C, et al. Rezūm therapy for ≥80-mL benign prostatic enlargement: a large, multicentre cohort study. BJU Int. 2022;130:522–527. https://doi.org/10.1111/bju.15753 DOI: https://doi.org/10.1111/bju.15753
de Assis AM, Moreira AM, de Paula Rodrigues VC, et al. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates >90 g: a prospective single-center study. J Vasc Interv Radiol. 2015;26:87–93. https://doi.org/10.1016/j.jvir.2014.10.012 DOI: https://doi.org/10.1016/j.jvir.2014.10.012
Manfredi C, García-Gómez B, Arcaniolo D, et al. Impact of surgery for benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis of erectile function and ejaculatory function. Eur Urol Focus. 2022;8:1711–1732. https://doi.org/10.1016/j.euf.2022.06.007 DOI: https://doi.org/10.1016/j.euf.2022.06.007
Checcucci E, Veccia A, De Cillis S, et al. New ultra-minimally invasive surgical treatment for benign prostatic hyperplasia: a systematic review and analysis of comparative outcomes. Eur Urol Open Sci. 2021;33:28–41. https://doi.org/10.1016/j.euros.2021.08.009 DOI: https://doi.org/10.1016/j.euros.2021.08.009
Nørby B, Nielsen HV, Frimodt-Møller PC. Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int. 2002;90:853–862. https://doi.org/10.1046/j.1464-410x.2002.03031.x DOI: https://doi.org/10.1046/j.1464-410X.2002.03031.x
Waldén M, Acosta S, Carlsson P, et al. A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: two-year follow-up. Scand J Urol Nephrol. 1998;32:204–210. https://doi.org/10.1080/003655998750015584 DOI: https://doi.org/10.1080/003655998750015584
De La Rosette JJMCH, Floratos DL, Severens JL, et al. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int. 2003;92:713–718. https://doi.org/10.1046/J.1464-410X.2003.04470.X DOI: https://doi.org/10.1046/j.1464-410X.2003.04470.x
Chughtai B, Rojanasarot S, Neeser K, et al. Cost-effectiveness and budget impact of emerging minimally invasive surgical treatments for benign prostatic hyperplasia. J Health Econ Outcomes Res. 2021;8:42–50. https://doi.org/10.36469/jheor.2021.22256 DOI: https://doi.org/10.36469/jheor.2021.22256
Aladesuru O, Punyala A, Stoddard M, et al. Review of the economics of surgical treatment options for benign prostatic hyperplasia. Curr Urol Rep. 2022;23:11–18. https://doi.org/10.1007/s11934-022-01083-z DOI: https://doi.org/10.1007/s11934-022-01083-z
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Lilli Winck-Flyvholm, Mikkel Fode, Anne Marsh, Kurt Krøyer Nielsen
This work is licensed under a Creative Commons Attribution 4.0 International License.
As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY license, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
